Results 221 to 230 of about 57,339 (296)

Testosterone Versus Clomiphene Treatment of Hypogonadism: A Retrospective Analysis in US Veterans

open access: yesAndrology, Volume 14, Issue 5, Page 1292-1299, July 2026.
ABSTRACT Background Male hypogonadotropic hypogonadism is a complex condition with a multifactorial etiology. Although testosterone replacement therapy (TRT) is the only approved treatment for male hypogonadism, clomiphene citrate (CC) is often used as an off‐label treatment.
Shourya Tadisina   +6 more
wiley   +1 more source

Causes of Persistent ST Elevation in Patients With Lung Cancer: A Case Report

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 4, July 2026.
ST elevation without Q waves in advanced cancer may suggest cardiac metastasis; voltage gradient while repolarization may cause ST elevation in cardiac metastasis. ABSTRACT Cardiac metastases are rare in clinical practice. Herein, we describe the case of a 61‐year‐old male patient who underwent radical left lung cancer surgery > 2 years before the ...
Lijiang Ding, Huayong Jin
wiley   +1 more source

An Unusual Etiology of Bayés' Syndrome: Fabry Disease

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 4, July 2026.
This patient with gene confirmed Fabry disease had advanced interatrial conduction block as seen on atrial‐specific vector tracing demonstrating sinus bradycardia with first‐degree AV block and sinus P‐wave terminal delay with biphasic morphology. The patient was later diagnosed with atrial fibrillation, which led to the diagnosis of Bayés' syndrome ...
Nicholas E. Kunce   +3 more
wiley   +1 more source

Bifidobacterium bifidum G9‐1 Intake Improves Gastrointestinal Symptoms in Type 2 Diabetes Mellitus: An Open‐Label, Randomized Controlled Trial (Binary STAR Study)

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5952-5967, July 2026.
ABSTRACT Aims To evaluate the effects of probiotics Bifidobacterium bifidum G9‐1 (BBG9‐1) on gastrointestinal symptoms in patients with Type 2 diabetes mellitus (T2DM) with diarrhoea or constipation. Materials and Methods In a 12‐week open‐label randomised controlled trial, 100 participants were randomized 1:1 to a control or BBG9‐1 group, with 12 mg ...
Genki Kobayashi   +10 more
wiley   +1 more source

Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6142-6150, July 2026.
ABSTRACT Aims The fibrosis‐4 (FIB‐4) score is used to identify risk of advanced liver fibrosis. This post hoc analysis investigated its prognostic value for cardiovascular (CV) outcomes and its relevance to the effects of dapagliflozin. Materials and Methods DECLARE‐TIMI 58 was a randomised, placebo‐controlled phase 3 trial investigating dapagliflozin ...
Jan Oscarsson   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy